An Acute Therapeutic Evaluation of Three Regimens of Tiotropium and Formoterol in COPD Patients: A Randomized, Double-blind, Placebo-Controlled Clinical Study
Mohammed Imran, Sunil Kumar Chhabra & Anita Kotwani · Journal of Advances in Medicine and Medical Research · 2015
Aims: To evaluate therapeutic rationality of combining long-acting β2-agonists (formoterol) with duration of action of 12 hours and anticholinergics (tiotropium) with 24 hours as fixed dose inhaled combination (FDC) still widely prescribed in developing countries in COPD patients...
Open access
Research Article
10.9734/BJMMR/2015/14053